CERENO SCIENTIFIC AB B (4A1) — Cash Flow-to-Debt Ratio
Latest as of June 2026:
0.08x
CERENO SCIENTIFIC AB B (4A1) has a Cash Flow-to-Debt Ratio of 0.08x as of June 2026, meaning its operating cash flow of €20.90 Million could theoretically repay 0% of its total liabilities (€261.12 Million) in one year. See 4A1 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
0.08x
Operating CF / Total Liabilities
Operating Cash Flow
€20.90 Million
EUR
Total Liabilities
€261.12 Million
EUR
Data as of
Jun 2026
Most recent filing
CERENO SCIENTIFIC AB B Cash Flow-to-Debt Ratio (2021–2025)
Historical debt coverage capacity for CERENO SCIENTIFIC AB B across 5 annual periods. For the full cash flow conversion analysis, see CERENO SCIENTIFIC AB B (4A1) cash conversion ratio.
Annual Cash Flow-to-Debt Ratio for CERENO SCIENTIFIC AB B (2021–2025)
Year-by-year debt coverage analysis for CERENO SCIENTIFIC AB B.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.75x | €-111.93 Million | €150.08 Million | ▼ -60.0% |
| 2024 | -0.47x | €-103.42 Million | €221.85 Million | ▲ +13.4% |
| 2023 | -0.54x | €-36.92 Million | €68.56 Million | ▲ +59.1% |
| 2022 | -1.32x | €-18.62 Million | €14.14 Million | ▼ -6.9% |
| 2021 | -1.23x | €-13.14 Million | €10.67 Million | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.